The association between hba1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Lind, Marcus ^a   Tuomilehto, Jaakko ^b,c,d   Uusitupa, Matti ^e   Nerman, Olle ^f   Eriksson, Johan ^c,g,h,i   LlanneParikka, Pirjo ^j   Keinänen Kiukaanniemi, Sirkka ^k,l   Peltonen, Markku ^c   Pivodic, Aldina ^m   Lindström, Jaana ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b DANUBE UNIVERSITY KREMS   (Austria)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^g VAASA CENTRAL HOSPITAL   (Finland)

^h FOLKHÄLSAN RESEARCH CENTER   (Finland)

ⁱ HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^j Finnish Diabetes Association   (Finland)

^k UNIVERSITY OF OULU   (Finland)

^l OULU UNIVERSITY HOSPITAL   (Finland)

^m Statistiska Konsultgruppen   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); ANALYSIS; BLOOD; CARDIOVASCULAR DISEASES; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; LIFESTYLE; MIDDLE AGED; PREDIABETIC STATE; RISK; TIME;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PREDIABETIC STATE; RISK; TIME FACTORS;

EID: 84907841761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109506     Document Type: Article

References (29)

1. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin pract. 94(3): 311-321.
2. Ford ES, Zhao G, Li C (2010) Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 55(13): 1310 -1317.
3. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 344(18): 1343-1350.
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346: 393-403.
5. Li G, Zhang P, Wang J, Gregg EW, Yang W, et al. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 371: 1783-1789.
6. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 354: 617-621.
7. NAVIGATOR Study Group, Holman RR, Haffher SM, McMurray JJ, Bethel MA, et al. (2010) Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 362: 1463-1476.
8. ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, et al. (2012) Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 367(4): 319-328.
9. Lind M, Odén A, Fahlén M, Eliasson B (2008) A systematic review of HbA1c variables used in the study of diabetic complications. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2: 282-293.
10. Parmar MKB, Machin D (1995) Survival Analysis: A Practical Approach. Wiley, Chichester ISBN: 0-471-93460-5.
11. The DECODE Study Group (Tuomilehto J) (2003) Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases. Diabetes Care. 26: 688-696.
12. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S (1996) GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care. 19: 450-456.
13. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, et al. (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia. 42: 926-931.
14. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW (2002) Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 25: 1845-1850.
15. Qiao Q, Dekker JM, de Vegt F, Nijpels G, Nissinen A, et al. (2004) Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbAlc. J Clin Epidemiol. 57: 590 -596.
16. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, et al. (2009) Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia. 52(3): 415-424.
17. Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J (2003) Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care. 26: 2910 -2914.
18. Monnier L, Colette C, Boniface H (2006) Contribution of postprandial glucose to chronic hyperglycaemia: from the "glucose triad" to the trilogy of "sevens". Diabetes Metab. 32 Spec No2: 2S11-6.
19. Riddle M, Umpierrez G, DiGenio A, Zhou R, Rosenstock J (2011) Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes. Diabetes Care. 34(12): 2508-2514.
20. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K (1993) Tenyear cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and nondiabetic subjects. Diabetologia. 36(11): 1175-1184.
21. Pajunen P, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, et al. (2011) Finnish Diabetes Prevention Study. HbA(lc) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabet Med. 28: 36-42.
22. the DE-PLAN-CAT Research Group, Costa B, Barrio F, Cabré JJ, Piñol JL, et al. (2011) Shifting from glucose diagnostic criteria to the new HbA(lc) criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population. Diabet Med. 28: 1234-1237.
23. Zensharen Study for Prevention of Lifestyle Diseases Group, Saito T, Watanabe M, Nishida J, Izumi T, et al. (2011) Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose Levels. A Randomized Controlled Trial. Arch Intern Med. 171: 1352-1360.
24. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, et al. (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 28(1): 88-136.
25. Eriksson KF, Lindgärde F (1991) Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia. 34(12): 891-898.
26. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, et al. (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 290(4): 486-94.
27. Uusitupa M, Peltonen M, Lindströmj, Aunola S, Ilanne-Parikka P, et al. (2009), for the Finnish Diabetes Prevention Study Group. Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study-Secondary Analysis of the Randomized Trial. PLoS ONE. 4: e5656.
28. Selvin E, Steifes MW, Zhu H, Matsushita K, Wagenknecht L, et al. (2010) Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults. N Engl J Med. 362: 800-811.
29. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British Medical Journal. 321: 405-412.